CORONARY INTERVENTIONS

Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry

EuroIntervention 2018;14:e562-e569 published online ahead of print May 2018 published online e-edition August 2018. DOI: 10.4244/EIJ-D-18-00392

Sergio Buccheri1,2, MD; Giovanna Sarno1*, MD, PhD; Bo Lagerqvist1, MD, PhD; Göran Olivecrona3, MD, PhD; Kristina Hambraeus4, MD, PhD; Nils Witt5, MD, PhD; Daniel Lindholm1, MD, PhD; David Erlinge3, MD, PhD; Oskar Angerås6, MD, PhD; Stefan James1, MD, PhD

1. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; 2. Fondazione Mediterranea G.B. Morgagni, Catania, Italy; 3. Department of Cardiology, Clinical Sciences, Lund University Hospital, Lu

Aims: The clinical performance of the SYNERGY drug-eluting stent (DES) in patients with acute myocardial infarction (MI) has not been investigated in detail. We sought to report on the ou

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

clinical researchnstemistemi

Share on Facebook Share on Twitter Share on Linkedin